- -- Quick Links --
-
- Home
- The focus
- Organizers
- FABA
- Pharmexcil
- Industry Speak
- BioAsia 2012
- BioAsia 2011
- BioAsia 2010
- BioAsia 2009
- Proceedings 2012
- Proceedings 2011
- Proceedings 2010
- Proceedings 2009
- Awards-2012
- Awards-2011
- Awards-2010
- Awards-2009
- Photo Gallery 2012
- Photo Gallery 2011
- Photo Gallery 2010
- Photo Gallery 2009
- Video Gallery 2012
- Video Gallery 2011
- Presentation
- Publications
- Contact Us
Archives
Archives
Agri Biotechnology
Dr. Anand Kumar
Dr P. Ananda Kumar is the Project Director of National Research Centre on Plant Biotechnology. He obtained M.Sc degree in Botany from Sri Venkateswara University, Tirupati. He joined as a Scientist in Agricultural Research Service of the Indian Council of Agricultural Research (ICAR) in 1978.
Dr. Aravind Kapur
I completed my Ph.D in 1980 in Plant Biochemistry. I worked as associate professor of Plant Breeding in Panjab agricultural university from 1980 -89. In 1989, I joined the Pioneer seed company which becomes Proagro in 1990.
Dr. K. K. Narayanan
Dr. K. K. Narayanan is the Managing Director of Metahelix Life Sciences; a Bangalore-based Ag-biotech Company that is focused on developing technologies for crop improvement. Metahelix has core competence in plant breeding, genomics and informatics combined with proven capabilities in the genetic transformation of several crop species including corn, cotton, rice and select vegetable species.
Dr. Selvaraj
Graduated with a Ph.D from Carleton University, Ottawa, Canada and after a post-doctoral research associateship joined the National Research Council of Canada laboratories in Saskatoon.
Dr. SR Rao
Dr.S.R.Rao, Adviser, Department of Biotechnology (DBT), Minister of Science & Technology, Government of India is Graduate in Agriculture with Ph.D in Mycology and Plant Pathology from Indian Agricultural Research Institute, New Delhi.
Animal Biotechnology
Dr. Matt Thomas
Dr Matt Thomas obtained his BSc at Cardiff University and his PhD at the University of Southampton in the UK. From 1991 to end of 2002 he worked as a research fellow at the Centre for Population Biology at Silwood Park, Imperial College London.
Dr. Nita Bharti
My work focuses on the spread of vaccine preventable human diseases in West African Nations. Specifically, I am interested in both spatial and temporal patterns of measles and meningitis in areas where vaccine coverage is patchy and birth rates are high.
Hudgson
Pasteurella multocida is an important veterinary pathogen with a diverse and complex structure, host range and virulence that causes pneumonic and systemic disease in bovids, fowl cholera in chickens and turkeys, atrophic rhinitis in pigs, and snuffles in rabbits.
Joe Shaw
Mr. Shaw has over 20 years experience in the development and commercialization of biotechnology innovations. He has extensive experience in strategic collaborating and raising funds from both public and private sources. Mr. Shaw's direct international experience includes Canada, Europe, South East Asia, China, and Japan.
Prof. Jay Bushan Rao
FASS/AAAS Congressional Science Fellow House of Representatives, Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, 316 Ford Bldg. Washington DC.
Richard Mole
Development of veterinary vaccines is a global industry valued at $3.5 billion. There are many common factors that affect the economics and practicalities of developing and manufacturing new livestock vaccines that occur irrespective of where these activities are undertaken, as well as differences that are territory specific.
Troy Ott
Viral diseases cause substantial morbidity and mortality in animal production systems. In addition, several high profile viruses have caused economic devastation to regional animal production systems in recent years. Furthermore, the list of OIE reportable diseases is dominated by virus-caused diseases.
Wansheng Liu
Viral diseases cause substantial morbidity and mortality in animal production systems. In addition, several high profile viruses have caused economic devastation to regional animal production systems in recent years. Furthermore, the list of OIE reportable diseases is dominated by virus-caused diseases.
Biopharmaceuticals
Dr Anand Kumar
Dr P. Ananda Kumar is the Project Director of National Research Centre on Plant Biotechnology. He obtained M.Sc degree in Botany from Sri Venkateswara University, Tirupati. He joined as a Scientist in Agricultural Research Service of the Indian Council of Agricultural Research (ICAR) in 1978.
Dr. Anand gautam
Anand Gautam has recently taken a position of Sourcing Director at Novo Nordisk, Denmark to help bring-in novel biologics to treat autoimmune diseases.
Dr. C. S N. Murthy
After India's compliance with the WTO requirements for product patents in 2005, the industry has expected many changes; but the emergence of Drug Discovery collaborations, a form of the Business of Science, has been a very unexpected offshoot.
Dr. Fernando de Mora
Professional with 22 years of experience in biomedical research (immunopharmacology – basic allergy and asthma) in technical and project management positions with a solid academic education in business administration. Drug development (R&D) consultant within the pharmaceutical and biotechnology sector.
Dr. Madhavan Nair
Opiates act synergistically with HIV-1 proteins to potentiate the HIV-related neurotoxicity that leads to development of NeuroAIDS. Currently no effective treatment exists for NeuroAIDS, which is mainly attributed to the impenetrability of therapeutic molecules across the blood-brain barrier (BBB).
Dr. Mahesh Bhalget
Dr. Mahesh Bhalgat has over 20 years of experience in the field of biotechnology and biologics. Following the completion of his B.Pharm from the University of Mumbai, Mahesh went to USA for advanced studies and completed his Ph.D. from the University of Utah.
Dr. Nagendra Linga Raj
Doctoral Research in Neurochemistry - Dissertation: In vitro and in vivo metabolism and pharmacokinetics of Disulfiram and S-S-Methyl N, N-diethylthiolcarbamate Sulfoxide
Dr. Nandini Kishore
Doctoral Research in Neurochemistry - Dissertation: In vitro and in vivo metabolism and pharmacokinetics of Disulfiram and S-S-Methyl N, N-diethylthiolcarbamate Sulfoxide
Dr. Pawan K Dhar
Senior Scientist & Lab Head, Synthetic Biology, RIKEN, Japan adjunct Professor, Tokyo Medical and Dental University visiting Scientist, Rajiv Gandhi Centre for Biotechnology, Trivandrum Visiting Faculty, Hyderabad Central University, Hyderabad
Dr. Pingfan rao
Dr.Rao Ping-fan is Professor and Director of Institute of Biotechnology, Fuzhou Universtiy, China. He earned his Bachelor of Food Technology from Fuzhou University in China in 1982, and Ph.D. in Biochemistry from Institute for Protein Research of Osaka University in Japan in 1989. He started teaching at Fuzhou University in 1989.
Dr. Prabhat arya
The post-genomic chemical biology age is challenging us to develop a better understanding protein-protein interaction-based signaling pathways and to examine their precise role(s) in regulation and de-regulation of cellular processes with an aim to exploit this knowledge in the modern drug discovery arena. Because these pathways are highly dynamic and temporal in nature, the classical approaches that utilize design strategies to access novel small molecules have been very difficult to apply.
Dr. Raghvendra Dubey
Dr. Raghvendra Krishna Dubey was born on 14th July 1960 in Lucknow, UP, India. He did his undergraduate studies in Lucknow and obtained degrees in Bachelor of Science and Master of Science from Lucknow University in 1977-1981.
Dr. Raman Venkat Raman
Raman Venkataramanan is a Professor of Pharmaceutical sciences at the University of Pittsburgh School of Pharmacy. He also holds a joint appointment as a Professor of Pathology in the University of Pittsburgh School of Medicine.
Dr. Sagarika
Sagarika Kanjilal, Departments of Pharmacology, College of Medicine, Pennsylvania State University at Hershey and Department of Veterinary and Biomedical Sciences, Penn State University, University Park, PA 16802.
Dr. Utpal Bhadra
Sagarika Kanjilal, Departments of Pharmacology, College of Medicine, Pennsylvania State University at Hershey and Department of Veterinary and Biomedical Sciences, Penn State University, University Park, PA 16802.
Dr. Van Gabain
Alexander von Gabain obtained his Ph.D. in Genetics at the University of Heidelberg and held a post-doctorate position at the Stanford University.
Dr.Yoshikazu Kurosawa
Alexander von Gabain obtained his Ph.D. in Genetics at the University of Heidelberg and held a post-doctorate position at the Stanford University.
Prof. P. Reddanna
Prof. P. Reddanna has been working for the past 30 years in the area of inflammation and cancer. He has standardized assay methods for lipoxygenase and cyclooxygenases, the target enzymes for the development of anti-inflammatory and anti-cancer drugs, their cloning, expression, purification and characterization.
Medical Biotechnology
Dr Agapois
Professor Agapios Sachinidis studied Chemistry and Biochemistry (Diploma: 1984) and got his PhD (1987) at the Institute of Biochemistry at the University of Münster in Germany. He was employed at the University of Zurich/Switzerland and Bonn/Germany and became 1998 in Bonn Prof. of Pathobiochemistry.
Dr. Boris Rubinsky
Rubinsky Boris was born in Romania and immigrated to Israel as a teenager. He graduated with a B.Sc. and M.Sc. in Mechanical Engineering from the Technion in Israel and with a PhD in Mechanical Engineering/Bioengineering from M.I.T., in 1981.
Dr. H.S. Chhabra
MBBS, MS (Orthopaedics), Post Graduate Certificate Course in Hospital Management – National Institute of Health & Family Welfare.
Dr. Janaki Ram
Dr. Ramachandran graduated from the University of Madras in India with Honours in Chemistry. He pursued graduate studies in the United States receiving the MS degree in Chemistry from De Paul University in Chicago and Ph.D. in Biochemistry from the University of California at Berkeley.
Dr. Joeri
Joeri Borstlap is co-ordinator of the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) at the Charité – Universitätsmedizin Berlin. He received his Master of Science in Architectural Engineering in 1996 from the University of Delft, The Netherlands.
Dr. Manmohan
Rapid and Real-Time detection of Emerging viruses of public health and BW importance – RTPCR, Multiplex PCR, Real-Time PCR, RTLAMP.
Dr. Mohan Rao
Dr. Ch. Mohan Rao combines biophysical, molecular biological and cell biological approaches to address problems of biomedical importance.
Dr. M.U.R. Naidu
Fundamental Course in Clinical Pharmacology, Grant Medical College, Bombay,1980. Workshop in Clinical Pharmacology, P. G. I., Chandigharh, 1980.
Dr. N.K. Mehra
Professor Narinder Mehra is the Head of the Department of Transplant Immunology & Immunogenetics at the All India Institute of Medical Sciences in New Delhi.
Dr. Narayana Raju
With the advent of MIS (Minimal Invasive Surgery) in the last two decade, an explosion of bio-medical engineering leading to medical device discoveries occurred in virtually all aspects of the conventional surgical approaches.
Dr. Oliver Blin
Olivier BLIN was born in Marseille (2 August 1960). After his training in the Marseille Medical School, he succeeded in the Paris Internship Paris (1983-1987). Certified in neurology and psychiatry (1988), he also qualified the Ph.D. « Doctorat d'Etat de Biologie Humaine (1990) » in the Pharmacology Department (La Salpétrière Hospital, Paris V Universiy).
Dr. PVL Rao
Dr. P.V.L. Rao is currently Scientist "F", Joint Director and Head, Division Virology & Bioprocess Scale-up Facility at Defence Research & Development Establishment, (DRDO) Gwalior.
Dr. Steinhoff
Regenerative Medicine, Tissue Engineering, Stem Cell Therapy. Basic research in stem cell therapy for myocardial regeneration. Basic research in non-viral gene therapy with magnetic nanoparticles
Dr.Amit Mishra CDRI
Amit Misra, Pharmaceutics Division, Central Drug Research Institute, Lucknow Interest in colloidal drug delivery systems (recently re-positioned as nanotechnology-enabled material) often induces a willingness to overlook a cost-benefit analysis of formulating nanometer-sized material.
Dr.Deepa Bharatiya
PhD from CDRI, Lucknow, Post Doc at NIH, worked at Wadia Hospital for Children and Reliance Life Sciences before joining National Institute for Research in Reproductive Health as Assistant Director and Head of Stem Cell Biology Department – which was established by her efforts.
Dr.Sameul Abraham
Dr Samuel JK Abraham, completed his primary medical education in Tirunelveli Medical College affiliated to Madurai Kamaraj University in 1992, TN, India.
Dr.Vivek Ahuja
Dr. Ahuja earned a Bachelor of Medicine and Bachelor of Surgery Degree from Government Medical College, Chandigarh, India and subsequently did his MD from AIIMS New Delhi.
Others
Dr. Janet
After graduating in Physics, Janet studied for her Ph.D. in Biophysics at the National Institute for Medical Research, Mill Hill, London (1970-1973).
Dr. Alfredo
The biotechnologies are an important group of technologies for the world. Industrial, agricultural biotechnologies provide enormous opportunities to address today's global challenges.
Dr. Rute
The world is changing. Both demographics and economics suggest that the 21st century will be the Asian century. In the European Union, we are also at a point of change, a newly elected European parliament and a new Commission being installed at this very moment.